Is ischemia-modified albumin reduction after coronary bypass surgery associated with the cardioprotective efficacy of cold-blood cardioplegia enriched with N-acetylcysteine : a preliminary study?
IMA may be used as not only an indicator of myocardial ischemia-reperfusion injury, but also as a useful indicator of the cardioprotective effect of NAC in CABG.
With thorough preparation of trainees and training on selected patients under close supervision, the learning curve can be overcome with good results even if the trainee has limited prior experience in open surgery.